Table 1.
Patient characteristics
| Baseline | 6 months | |
|---|---|---|
| DAS28CRP | 5.7 (5.1-6.5) | 2.1 (1.8-2.8) |
| Swollen joint count (0-28) | 10 (7.0-17) | 0 (0-0) |
| Tender joint count (0-28) | 12 (7.0-18) | 0 (0-1.3) |
| Swollen joint count (0-40) | 13 (9.0-22) | 0 (0-0) |
| Tender joint count (0-40) | 17 (11-26) | 0 (0-3.0) |
| VAS doctor global (0-100 mm) | 56 (41-73) | 2.0 (0-10) |
| CRP (mg/ml) | 15 (7.0-42) | 7.0 (7.0-7.0) |
| SDAI (0.7-82) | 37 (29-47) | 3.1 (0.86-7.0) |
| IgM-RF (% positive) | 70.7% | - |
| Anti-CCP (% positive) | 62.7% | - |
| TSS (% positive) | 17.3% | - |
Relevant disease markers at baseline and following 6 months of treatment. Data are expressed as median with interquartile range (IQR). Anti-CCP: anti-citrullinated protein antibody; CRP: C-reactive protein; DAS28CRP: disease activity in 28 joints, four variables, C-reactive protein based; IgM-RF: IgM rheumatic factor; SDAI: simple disease activity index; TSS: total Sharp score; VAS: visual analog scale.